Company Profile

Nastech Pharmaceutical Company Inc.

Name change to MDRNA, Inc.
3450 Monte Villa Parkway
Bothell Washington 98021 U.S.A.
Phone: 425-908-3600 Fax: 425-908-3650

Industry
Biotechnology

Segment
Drug Delivery

Collaborations
Merck & Co. Obesity

Company News

Nastech Pharmaceutical Company Inc. (NSTK) Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer 6/10/2008 2:30:58 PM

Nastech Pharmaceutical Company Inc. (NSTK) Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting 6/9/2008 10:31:48 AM

Nastech Pharmaceutical Company Inc. (NSTK) Announces First Quarter 2008 Financial Results 5/9/2008 9:04:52 AM

Nastech Pharmaceutical Company Inc. (NSTK) to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008 5/2/2008 10:07:12 AM

Nastech Pharmaceutical Company Inc. (NSTK) Raises $7.93 Million in Registered Direct Offering 4/25/2008 6:10:23 AM

Nastech Pharmaceutical Company Inc. (NSTK) Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board 3/27/2008 8:44:49 AM

Nastech Pharmaceutical Company Inc. (NSTK) to Present RNAi Data 3/25/2008 10:48:58 AM

Nastech Pharmaceutical Company Inc. (NSTK) Complies with Nasdaq Marketplace Rule 4350(b)(1)(B) 3/24/2008 10:19:52 AM

Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company Inc. (NSTK) 3/19/2008 9:59:47 AM

Nastech Pharmaceutical Company Inc. (NSTK) Announces Fourth Quarter and Full Year 2007 Financial Results 3/18/2008 10:38:42 AM

...

//-->